Loading…
sealvo.com · USPTO Trademark Record
https://sealvo.com/novosource-77410009

Surgical, medical, dental and veterinary apparatus and instruments; artificial limbs, eyes and teeth; spectacles, contact lenses and sunglasses; orthopaedic articles; suture materials; therapeutic and assistive devices adapted for persons with disabilities; massage apparatus; apparatus, devices and articles for nursing infants; sexual activity apparatus, devices and articles.; Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.
NOVOSOURCE (Serial No. 77410009), Registration No. 0, is a abandoned US trademark filed on Feb 29, 2008 by iMDs Holdings Corp.. This trademark covers Class 010 (Surgical, medical, dental & veterinary apparatus), Class 042 (Scientific, technology & SaaS services).
Surgical, medical, dental and veterinary apparatus and instruments; artificial limbs, eyes and teeth; spectacles, contact lenses and sunglasses; orthopaedic articles; suture materials; therapeutic and assistive devices adapted for persons with disabilities; massage apparatus; apparatus, devices and articles for nursing infants; sexual activity apparatus, devices and articles.
Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.
This description is as filed with the USPTO and defines the scope of trademark protection.
Recently filed and registered marks in the same international class.
AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.
Free USPTO lookups by name, owner, or serial number. No account needed.
Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.